Come up with a name for your new list and we'll add to it:
Symbiomix Therapeutics was acquired by
Lupin on October 11, 2017.
Symbiomix is a held biopharmaceutical company with a focus on women's health. The company's lead product, SYM-1219, is a new anti-infective drug being studied as the first oral one-and-done treatment …